Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.69 is 48% below its 5-year average of 5.14, near the low end of its 5-year range (1.96–10.84).
As of the fiscal period ended Tuesday, June 30, 2026. 4.16% above its 12-month average of 2.58.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.69.
CURRENT RATIO
2.69
CURRENT RATIO AVG TTM
2.58
CURRENT RATIO AVG 3Y
3.60
CURRENT RATIO AVG 5Y
5.14
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.16%
CURRENT VS 3Y AVG
-25.44%
CURRENT VS 5Y AVG
-47.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-28.33%
vs the sector median at left
Market Cap
$629.87M
Current Ratio
5.17
TTM Avg
4.10
3Y Avg
4.28
5Y Avg
7.57
Market Cap
$636.13M
Current Ratio
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$601.84M
Current Ratio
6.06
TTM Avg
2.91
3Y Avg
9.31
5Y Avg
9.54
Market Cap
$656.34M
Current Ratio
1.36
TTM Avg
1.59
3Y Avg
1.59
5Y Avg
1.59
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SOPHiA GENETICS S.A. (SOPH) | $625.86M | 2.69 | 2.58 | 3.60 | 5.14 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $629.87M | 5.17 | 4.10 | 4.28 | 7.57 |
| Climb Bio, Inc. (CLYM)vs › | $618.02M | 31.45 | 23.29 | 26.88 | 23.21 |
| OmniAb, Inc. (OABI)vs › | $635.70M | 4.80 | 4.27 | 4.36 | 3.29 |
| Aura Biosciences, Inc. (AURA)vs › | $636.13M | 16.82 | 9.46 | 14.12 | 14.05 |
| Prime Medicine, Inc. (PRME)vs › | $640.29M | 3.05 | 5.21 | 6.01 | 5.25 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.84M | 6.06 | 2.91 | 9.31 | 9.54 |
| Starling Oncology, Inc. (STLN)vs › | $656.34M | 1.36 | 1.59 | 1.59 | 1.59 |
| AngioDynamics, Inc. (ANGO)vs › | $594.45M | 2.19 | 2.20 | 2.12 | 2.14 |
| MiMedx Group, Inc. (MDXG)vs › | $662.48M | 5.33 | 4.27 | 3.79 | 3.57 |
Current Ratio
2.69
Quick Ratio
2.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.69 |
| 2026-03-31 | 2.06 |
| 2025-12-31 | 1.96 |
| 2025-09-30 | 2.80 |
| 2025-06-30 | 3.39 |
| 2025-03-31 | 3.11 |
| 2024-12-31 | 3.71 |
| 2024-09-30 | 3.80 |
| 2024-06-30 | 4.40 |
| 2024-03-31 | 4.14 |
| 2023-12-31 | 4.16 |
| 2023-09-30 | 5.30 |
| 2023-06-30 | 5.34 |
| 2023-03-31 | 6.21 |
| 2022-12-31 | 7.32 |
| 2022-09-30 | 7.42 |
| 2022-06-30 | 7.58 |
| 2022-03-31 | 8.63 |
| 2021-12-31 | 9.89 |
| 2021-09-30 | 10.84 |
| 2021-06-30 | 3.22 |
| 2021-03-31 | 4.36 |
| 2020-12-31 | 5.08 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
